Be A Freedom Fighter · Bill Library
HR 10937 — PROTECT 340B Act of 2026
Freedom score: -2 (scale −10 to +10)
- Individual rights: +1
- Property rights: 0
- Economic freedom: -2
- Privacy & due process: 0
- Government power: -1
Sponsor: Rep. Matsui, Doris O. [D-CA-7] · Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2026-10-29)
Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index
Findings — 17 highlighted provisions
Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.
- Sec. 3(a), new PHSA §2730(b)(3) · Individual Rights — Plans, insurers and PBMs may not interfere with enrollee choice to obtain a 340B drug through a covered entity or contract pharmacy, including delivery/mail. Affects enrollees and intermediaries; enforced through new PBM penalties and existing plan regulation See in text ↓
- Sec. 3(a), new PHSA §2730(a) · Economic Freedom — Bars discriminatory reimbursement, exclusion and participation terms based on 340B status or activity; enforced by §2730(c) and plan requirements See in text ↓
- Sec. 3(a), new §2730(b)(1) · Economic Freedom — Bars lower 340B reimbursement solely due to participation compared with similarly situated non-340B providers See in text ↓
- Sec. 3(a), new §2730(b)(2)(A)–(E) · Economic Freedom — Bars discriminatory fees, chargebacks, clawbacks, network terms, audit/inventory rules and HRSA-identified interfering practices See in text ↓
- Sec. 3(a), new §2730(b)(4)–(6) · Economic Freedom — Bars compelled identification of 340B drugs, discriminatory contracting refusal and denial of coverage based solely on 340B status See in text ↓
- Sec. 3(b)(1)–(2) · Economic Freedom — Applies the requirements to Medicare Part D sponsors/PBMs and makes a Medicare Advantage cross-reference amendment See in text ↓
- Sec. 3(d) · Economic Freedom — Prohibits spending to implement Executive Order 13937 or specified HHS restrictions on 340B patient charges See in text ↓
- Sec. 3(e) · Economic Freedom — Terminates the 340B Rebate Model Pilot on enactment and prohibits substantially similar programs See in text ↓
- Sec. 3(c)(1), new SSA §1927(l)(1) · Privacy and Due Process — HHS must contract with an independent third party within one year to identify Medicaid 340B claims and duplicate discounts See in text ↓
- Sec. 3(c)(1), new §1927(l)(2)(A)(i)–(iii) · Privacy and Due Process — Contractor requests/reviews claim-level data, maintains confidentiality and notifies state agencies of duplicate discounts See in text ↓
- Sec. 3(c)(1), new §1927(l)(2)(B) · Privacy and Due Process — Covered entities may report retrospectively rather than identify all 340B claims at point of sale See in text ↓
- Sec. 3(c)(2)(A)–(B) · Privacy and Due Process — Covered entities/states provide data and remove duplicate-discount claims from rebate requests See in text ↓
- Sec. 3(a), new §2730(b)(4) · Privacy and Due Process — Limits compelled 340B identification, separately from Medicaid verification See in text ↓
- Sec. 3(a), new §2730(c) · Government Power — HHS PBM civil penalties up to $5,000 per violation per day; proposed rules within 60 days and final rules within 180 days See in text ↓
- Sec. 3(a), new §2730(d)(1)–(3) · Government Power — Defines covered entities, contracted pharmacies (including mail) and 340B drugs See in text ↓
- Sec. 3(b)–(c) · Government Power — Extends Medicare contract requirements and establishes Medicaid duplicate-discount verification See in text ↓
- Sec. 3(d)–(e) · Government Power — Restricts HHS spending, patient-charge limitations and rebate-model programs See in text ↓
Full text (introduced version)
24 of 41 text blocks highlighted. Source: GovInfo, fetched cached.
SECTION 1. SHORT TITLE.
SEC. 2. FINDINGS AND PURPOSE.
SEC. 3. ENSURING THE EQUITABLE TREATMENT OF COVERED ENTITIES AND PHARMACIES PARTICIPATING IN THE 340B DRUG DISCOUNT PROGRAM.
Sec. 3(a), new PHSA §2730(b)(3) · Individual Rights — Plans, insurers and PBMs may not interfere with enrollee choice to obtain a 340B drug through a covered entity or contract pharmacy, including delivery/mail. Affects enrollees and intermediaries; enforced through new PBM penalties and existing plan regulation
Sec. 3(a), new PHSA §2730(a) · Economic Freedom — Bars discriminatory reimbursement, exclusion and participation terms based on 340B status or activity; enforced by §2730(c) and plan requirements
Sec. 3(a), new §2730(b)(1) · Economic Freedom — Bars lower 340B reimbursement solely due to participation compared with similarly situated non-340B providers
Sec. 3(a), new §2730(b)(2)(A)–(E) · Economic Freedom — Bars discriminatory fees, chargebacks, clawbacks, network terms, audit/inventory rules and HRSA-identified interfering practices
Sec. 3(a), new §2730(b)(4)–(6) · Economic Freedom — Bars compelled identification of 340B drugs, discriminatory contracting refusal and denial of coverage based solely on 340B status
Sec. 3(a), new §2730(b)(4) · Privacy and Due Process — Limits compelled 340B identification, separately from Medicaid verification
Sec. 3(a), new §2730(c) · Government Power — HHS PBM civil penalties up to $5,000 per violation per day; proposed rules within 60 days and final rules within 180 days
Sec. 3(a), new §2730(d)(1)–(3) · Government Power — Defines covered entities, contracted pharmacies (including mail) and 340B drugs
Sec. 3(a), new PHSA §2730(a) · Economic Freedom — Bars discriminatory reimbursement, exclusion and participation terms based on 340B status or activity; enforced by §2730(c) and plan requirements
Sec. 3(a), new PHSA §2730(b)(3) · Individual Rights — Plans, insurers and PBMs may not interfere with enrollee choice to obtain a 340B drug through a covered entity or contract pharmacy, including delivery/mail. Affects enrollees and intermediaries; enforced through new PBM penalties and existing plan regulation
Sec. 3(a), new §2730(b)(1) · Economic Freedom — Bars lower 340B reimbursement solely due to participation compared with similarly situated non-340B providers
Sec. 3(a), new §2730(b)(2)(A)–(E) · Economic Freedom — Bars discriminatory fees, chargebacks, clawbacks, network terms, audit/inventory rules and HRSA-identified interfering practices
Sec. 3(a), new §2730(b)(4)–(6) · Economic Freedom — Bars compelled identification of 340B drugs, discriminatory contracting refusal and denial of coverage based solely on 340B status
Sec. 3(a), new §2730(b)(4) · Privacy and Due Process — Limits compelled 340B identification, separately from Medicaid verification
Sec. 3(a), new §2730(b)(1) · Economic Freedom — Bars lower 340B reimbursement solely due to participation compared with similarly situated non-340B providers
Sec. 3(a), new §2730(b)(2)(A)–(E) · Economic Freedom — Bars discriminatory fees, chargebacks, clawbacks, network terms, audit/inventory rules and HRSA-identified interfering practices
Sec. 3(a), new PHSA §2730(b)(3) · Individual Rights — Plans, insurers and PBMs may not interfere with enrollee choice to obtain a 340B drug through a covered entity or contract pharmacy, including delivery/mail. Affects enrollees and intermediaries; enforced through new PBM penalties and existing plan regulation
Sec. 3(a), new §2730(b)(4)–(6) · Economic Freedom — Bars compelled identification of 340B drugs, discriminatory contracting refusal and denial of coverage based solely on 340B status
Sec. 3(a), new §2730(b)(4) · Privacy and Due Process — Limits compelled 340B identification, separately from Medicaid verification
Sec. 3(a), new §2730(b)(4)–(6) · Economic Freedom — Bars compelled identification of 340B drugs, discriminatory contracting refusal and denial of coverage based solely on 340B status
Sec. 3(a), new §2730(b)(4)–(6) · Economic Freedom — Bars compelled identification of 340B drugs, discriminatory contracting refusal and denial of coverage based solely on 340B status
Sec. 3(a), new §2730(c) · Government Power — HHS PBM civil penalties up to $5,000 per violation per day; proposed rules within 60 days and final rules within 180 days
Sec. 3(a), new §2730(d)(1)–(3) · Government Power — Defines covered entities, contracted pharmacies (including mail) and 340B drugs
Sec. 3(a), new §2730(d)(1)–(3) · Government Power — Defines covered entities, contracted pharmacies (including mail) and 340B drugs
Sec. 3(a), new §2730(d)(1)–(3) · Government Power — Defines covered entities, contracted pharmacies (including mail) and 340B drugs
Sec. 3(a), new §2730(d)(1)–(3) · Government Power — Defines covered entities, contracted pharmacies (including mail) and 340B drugs
Sec. 3(b)(1)–(2) · Economic Freedom — Applies the requirements to Medicare Part D sponsors/PBMs and makes a Medicare Advantage cross-reference amendment
Sec. 3(b)–(c) · Government Power — Extends Medicare contract requirements and establishes Medicaid duplicate-discount verification
Sec. 3(b)(1)–(2) · Economic Freedom — Applies the requirements to Medicare Part D sponsors/PBMs and makes a Medicare Advantage cross-reference amendment
Sec. 3(b)–(c) · Government Power — Extends Medicare contract requirements and establishes Medicaid duplicate-discount verification
Sec. 3(b)(1)–(2) · Economic Freedom — Applies the requirements to Medicare Part D sponsors/PBMs and makes a Medicare Advantage cross-reference amendment
Sec. 3(b)–(c) · Government Power — Extends Medicare contract requirements and establishes Medicaid duplicate-discount verification
Sec. 3(c)(1), new SSA §1927(l)(1) · Privacy and Due Process — HHS must contract with an independent third party within one year to identify Medicaid 340B claims and duplicate discounts
Sec. 3(c)(1), new §1927(l)(2)(A)(i)–(iii) · Privacy and Due Process — Contractor requests/reviews claim-level data, maintains confidentiality and notifies state agencies of duplicate discounts
Sec. 3(c)(1), new §1927(l)(2)(B) · Privacy and Due Process — Covered entities may report retrospectively rather than identify all 340B claims at point of sale
Sec. 3(c)(2)(A)–(B) · Privacy and Due Process — Covered entities/states provide data and remove duplicate-discount claims from rebate requests
Sec. 3(b)–(c) · Government Power — Extends Medicare contract requirements and establishes Medicaid duplicate-discount verification
Sec. 3(c)(1), new SSA §1927(l)(1) · Privacy and Due Process — HHS must contract with an independent third party within one year to identify Medicaid 340B claims and duplicate discounts
Sec. 3(c)(1), new §1927(l)(2)(A)(i)–(iii) · Privacy and Due Process — Contractor requests/reviews claim-level data, maintains confidentiality and notifies state agencies of duplicate discounts
Sec. 3(c)(1), new §1927(l)(2)(B) · Privacy and Due Process — Covered entities may report retrospectively rather than identify all 340B claims at point of sale
Sec. 3(b)–(c) · Government Power — Extends Medicare contract requirements and establishes Medicaid duplicate-discount verification
Sec. 3(c)(1), new SSA §1927(l)(1) · Privacy and Due Process — HHS must contract with an independent third party within one year to identify Medicaid 340B claims and duplicate discounts
Sec. 3(c)(1), new §1927(l)(2)(A)(i)–(iii) · Privacy and Due Process — Contractor requests/reviews claim-level data, maintains confidentiality and notifies state agencies of duplicate discounts
Sec. 3(c)(1), new §1927(l)(2)(B) · Privacy and Due Process — Covered entities may report retrospectively rather than identify all 340B claims at point of sale
Sec. 3(c)(1), new SSA §1927(l)(1) · Privacy and Due Process — HHS must contract with an independent third party within one year to identify Medicaid 340B claims and duplicate discounts
Sec. 3(c)(1), new §1927(l)(2)(A)(i)–(iii) · Privacy and Due Process — Contractor requests/reviews claim-level data, maintains confidentiality and notifies state agencies of duplicate discounts
Sec. 3(c)(1), new §1927(l)(2)(B) · Privacy and Due Process — Covered entities may report retrospectively rather than identify all 340B claims at point of sale
Sec. 3(d) · Economic Freedom — Prohibits spending to implement Executive Order 13937 or specified HHS restrictions on 340B patient charges
Sec. 3(d)–(e) · Government Power — Restricts HHS spending, patient-charge limitations and rebate-model programs
Sec. 3(e) · Economic Freedom — Terminates the 340B Rebate Model Pilot on enactment and prohibits substantially similar programs
Sec. 3(d)–(e) · Government Power — Restricts HHS spending, patient-charge limitations and rebate-model programs
Findings source: bill-scores-v2-batch26-findings-2026-11-14.md. Highlights come only from that file; no finding, score, or provision was invented for this page.
What you can do
Contact your U.S. Representative and Senators about this bill.
Find your Representative Contact your Senators
Spot an error on this page? Report it.